Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    8777713 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Terminated HGS-ETR2 to Treat Children With Solid Tumors
Conditions: Ewing's Sarcoma;   Osteosarcoma;   Neuroblastoma;   Rhabdomyosarcoma
Interventions: Drug: Lexatumumab alone;   Drug: Lexatumumab in combination;   Drug: Interferon gamma 1b in combination;   Drug: Gamma 1b potential expansion

Study has passed its completion date and status has not been verified in more than two years.